Feedback
Settings

Settings

Goto Application

1. WO2000024747 - SUBSTANCE GM-95, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF

PermaLink
Publication Number WO/2000/024747
Publication Date 04.05.2000
International Application No. PCT/JP1999/005806
International Filing Date 20.10.1999
Chapter 2 Demand Filed 31.03.2000
IPC
C07D 513/00 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
513Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/, C07D477/232
C07D 513/22 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
513Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/, C07D477/232
22in which the condensed system contains four or more hetero rings
C12P 17/18 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
17Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms
18containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
CPC
C07D 513/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
513Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D 513/22
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
513Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
22in which the condensed system contains four or more hetero rings
C12P 17/185
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
17Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
18containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
185Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
Applicants
  • TAIHO PHARMACEUTICAL CO., LTD. [JP]/[JP] (AllExceptUS)
  • SOSEI CO., LTD. [JP]/[JP] (AllExceptUS)
  • SETO, Haruo [JP]/[JP] (UsOnly)
  • SHIN-YA, Kazuo [JP]/[JP] (UsOnly)
  • WIERZBA, Konstanty [PL]/[JP] (UsOnly)
Inventors
  • SETO, Haruo
  • SHIN-YA, Kazuo
  • WIERZBA, Konstanty
Agents
  • SAEGUSA, Eiji
Priority Data
10/30263423.10.1998JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) SUBSTANCE GM-95, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
(FR) SUBSTANCE GM-95, PROCEDES DE FABRICATION ET D'UTILISATION CORRESPONDANTS
front page image
Abstract
(EN)
A compound represented by formula (1); a process for producing the same; medicinal compositions containing the above compound as the active ingredient; a method for treating tumor by administering the compound; utilization of the compound in drugs; and a bacterium capable of producing the compound. The above compound is a novel compound having an antitumor effect and being useful as drugs.
(FR)
L'invention concerne un composé correspondant à la formule suivante (1); un procédé de fabrication correspondant; des compositions médicinales contenant ce composé en tant que composant actif; un procédé de traitement des tumeurs qui consiste à administrer ce composé; l'utilisation de ce composé dans des médicaments; et une bactérie capable de fabriquer ce composé. (1) le composé est un nouveau composé ayant un effet anti-tumoral et utile en tant que médicament.
Also published as
EP1123937
CA2346201
DE000069917668
PT1123937
AU1999062277
DK1123937
JPWO2000024747
US6613759
KR1020010103610
US20030191165
Latest bibliographic data on file with the International Bureau
# -